| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Change in fair value of convertible notes | -64,369 | 213,930 | -92,479 | - |
| Total other (expense) income | -80,360 | 203,941 | -101,766 | -732,521 |
| Net loss | -2,347,302 | -3,706,465 | -3,053,007 | -3,784,082 |
| Net loss per shares - basic | -1.05 | -3.29 | -0.3 | -1.59 |
| Net loss per shares - diluted | -1.05 | -3.29 | -0.3 | -1.59 |
| Weighted average common shares outstanding - basic | 2,233,650 | 1,126,054 | 10,048,915 | 2,384,177 |
| Weighted average common shares outstanding - diluted | 2,233,650 | 1,126,054 | 10,048,915 | 2,384,177 |
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)